quinazolines has been researched along with Brain Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, TM; Wong, AS; Zee, YK | 1 |
| Barabás, P; Kardos, J; Kökösi, J; Kovács, I; LaszTóczi, B; Nagy, PI; Nyikos, L; Skuban, N; Szárics, E; Takácsné, NK | 1 |
2 other study(ies) available for quinazolines and Brain Disorders
| Article | Year |
|---|---|
Fatal cystic change of brain metastasis after response to gefitinib in non-small-cell lung cancer.
Topics: Antineoplastic Agents; Brain Diseases; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cysts; Fatal Outcome; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines; Tomography, X-Ray Computed | 2009 |
[EFfect of quinazolone-alkyl-carboxylic acid derivatives on the transmembrane Ca2+ ion flux mediated by AMPA receptors].
Topics: Alkylation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Brain Diseases; Calcium; Carboxylic Acids; Cell Membrane; Humans; Quinazolines; Receptors, AMPA | 2002 |